Human Umbilical Cord Mesenchymal Stem Cells Improve Locomotor Function in Parkinson’s Disease Mouse Model Through Regulating Intestinal Microorganisms
Authors:
Open Access
- 20 January 2022
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Cell and Developmental Biology
- Vol. 9, 808905
Abstract
Parkinson’s disease (PD) is a progressive neurological disorder characterized by loss of neurons that synthesize dopamine, and subsequent impaired movement. Umbilical cord mesenchymal stem cells (UC-MSCs) exerted neuroprotection effects in a rodent model of PD. However, the mechanism underlying UC-MSC-generated neuroprotection was not fully elucidated. In the present study, we found that intranasal administration of UC-MSCs significantly alleviated locomotor deficits and rescued dopaminergic neurons by inhibiting neuroinflammation in a PD mouse model induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP, a toxic agent which selectively destroys nigrostriatal neurons but does not affect dopaminergic neurons elsewhere). Furthermore, UC-MSC treatment altered gut microbiota composition characterized by decreased phylum Proteobacteria, class Gammaproteobacteria, family Enterobacteriaceae, and genus Escherichia-Shigella. In addition, the neurotransmitter dopamine in the striatum and 5-hydroxytryptamine in the colon were also modulated by UC-MSCs. Meanwhile, UC-MSCs significantly maintained intestinal goblet cells, which secrete mucus as a mechanical barrier against pathogens. Furthermore, UC-MSCs alleviate the level of TNF-α and IL-6 as well as the conversion of NF-κB expression in the colon, indicating that inflammatory responses were blocked by UC-MSCs. PICRUSt showed that some pathways including bacterial invasion of epithelial cells, fluorobenzoate degradation, and pathogenic Escherichia coli infection were significantly reversed by UC-MSCs. These data suggest that the beneficial effects were detected following UC-MSC intranasal transplantation in MPTP-treated mice. There is a possible neuroprotective role of UC-MSCs in MPTP-induced PD mice by cross talk between the brain and gut.Keywords
This publication has 73 references indexed in Scilit:
- Neuroprotective effects of mesenchymal stem cells through autophagy modulation in a parkinsonian modelNeurobiology of Aging, 2014
- Geraniol attenuates α-synuclein expression and neuromuscular impairment through increase dopamine content in MPTP intoxicated mice by dose dependent mannerBiochemical and Biophysical Research Communications, 2013
- Geraniol Ameliorates the Motor Behavior and Neurotrophic Factors Inadequacy in MPTP-Induced Mice Model of Parkinson’s DiseaseJournal of Molecular Neuroscience, 2013
- The prion hypothesis in Parkinson's disease: Braak to the futureActa Neuropathologica Communications, 2013
- Mucosal Barrier in Ulcerative Colitis and Crohn’s DiseaseGastroenterology Research and Practice, 2013
- Comparison of human mesenchymal stem cells derived from adipose and cord tissueCytotherapy, 2013
- Mesenchymal stem cells enhance survival and bacterial clearance in murineEscherichia colipneumoniaThorax, 2012
- The Expanded Biology of SerotoninAnnual Review of Medicine, 2009
- Neuroprotective effects of human mesenchymal stem cells on dopaminergic neurons through anti‐inflammatory actionGlia, 2008
- Serotonin Function and the Mechanism of Antidepressant ActionArchives of General Psychiatry, 1990